```html

Reflex Sympathetic Dystrophy (Complex Regional Pain Syndrome)

Overview

Reflex Sympathetic Dystrophy (RSD), now more formally called Complex Regional Pain Syndrome type I (CRPS‑I), is a chronic pain condition that usually develops after an injury, surgery, or immobilization of an arm or leg. It is characterized by severe, burning pain that is out of proportion to the original injury, along with swelling, changes in skin temperature and color, and motor dysfunction. When an identifiable nerve injury is present, the condition is classified as CRPS type II.

Who it affects: RSD can affect anyone, but it is most common in women (about 60‑70 % of cases) and typically occurs between the ages of 40 and 60. The condition often follows a fracture, sprain, surgery, or even a seemingly minor crush injury.

Prevalence: Estimates vary because CRPS is under‑diagnosed. According to the U.S. National Institutes of Health (NIH), CRPS affects roughly 5–26 per 100,000 people each year, with higher rates reported in orthopedic and pain‑management clinics. The condition accounts for up to 5 % of all fractures and 13 % of all joint replacements in the United States <sup>[1]</sup>.

Symptoms

Symptoms usually appear within days to months after the precipitating event and may progress in stages. The classic triad – pain, autonomic changes, and motor/trophic disturbances – helps clinicians recognise the disorder.

Primary symptoms

• Severe, burning or “pins‑and‑needles” pain – often described as continuous and disproportionate to the injury.
• Allodynia – pain from light touch (e.g., clothing, a gentle brush).
• Hyperalgesia – heightened pain response to normally painful stimuli.

Autonomic (sympathetic) signs

• Swelling (edema) that may be warm or cool to the touch.
• Skin color changes – pink, red, mottled, or bluish.
• Temperature asymmetry – the affected limb can feel noticeably hotter or cooler than the opposite side.
• Excessive sweating (hyperhidrosis) over the involved area.

Motor and trophic changes

• Stiffness and reduced range of motion.
• Muscle weakness or atrophy over time.
• Claw‑like hand deformities (in wrist/hand involvement) or foot drop (in lower‑extremity cases).
• Thinning of skin, hair loss, or brittle nails on the affected limb.

Progressive stages (optional)

1. Stage 1 (acute) – Intense pain, swelling, and autonomic changes.
2. Stage 2 (dystrophic) – Persistent pain, skin changes, and beginning of muscle wasting.
3. Stage 3 (atrophic) – Severe atrophy, contractures, and chronic disability.

Causes and Risk Factors

RSD is not fully understood, but several mechanisms are thought to act together:

Pathophysiologic contributors

• Peripheral nerve sensitisation – injury leads to abnormal firing of nociceptors.
• Central sensitisation – the spinal cord and brain amplify pain signals.
• Autonomic dysregulation – abnormal sympathetic activity causes vascular and sweating changes.
• Inflammatory cascade – release of cytokines (e.g., TNF‑α, IL‑1β) that perpetuate swelling and pain.
• Genetic predisposition – some studies suggest polymorphisms in genes related to pain processing increase susceptibility <sup>[2]</sup>.

Typical triggers

• Fractures (especially of the wrist, ankle, or foot).
• Sprains, dislocations, or crush injuries.
• Surgical procedures – particularly orthopedic or vascular surgeries.
• Prolonged immobilisation (e.g., casting, splinting).
• Minor injuries that heal quickly but are followed by disproportionate pain.

Risk factors

• Female gender (2–3 times more common).
• Age 40‑60 years (though it can occur at any age).
• History of migraine, asthma, or other chronic pain syndromes.
• Psychological stress or anxiety disorders – not a cause, but they can worsen perception of pain.
• Smoking and poor vascular health, which may amplify sympathetic responses.

Diagnosis

Because RSD mimics many other conditions, a careful, systematic approach is essential.

Clinical criteria

Most clinicians use the Bouquet‑Bardin “Budapest” criteria, which require:

• Continuing pain that is disproportionate to any inciting event.
• At least one symptom in three of the following categories: sensory, vasomotor, sudomotor/edema, motor/trophic.
• At least one sign in two or more of those categories on physical exam.
• Absence of an alternative diagnosis that better explains the signs and symptoms.

Laboratory and imaging studies

• Plain X‑ray – Usually normal early; later may show demineralisation (osteopenia).
• Three‑phase bone scintigraphy – Shows increased uptake in the affected limb in early disease (sensitivity ~80 %).
• MRI – Helpful to rule out occult fractures, joint effusions, or soft‑tissue pathology.
• Thermography – Detects temperature asymmetry; not routinely required but supportive.

Exclusion of other conditions

Clinicians must rule out deep‑vein thrombosis, infection, cellulitis, arthritis, peripheral neuropathy, and vascular occlusion.

Treatment Options

Early, multidisciplinary treatment improves outcomes. Management combines medication, physical therapy, interventional procedures, and psychosocial support.

Pharmacologic therapy

• NSAIDs – First‑line for mild pain and inflammation (ibuprofen, naproxen). Use per FDA dosing guidelines.
• Neuropathic pain agents –
  • Gabapentin (300‑1200 mg/day) or pregabalin (150‑600 mg/day) – effective for burning pain.
  • Tricyclic antidepressants (amitriptyline 10‑50 mg nightly) – also aid sleep.
• Corticosteroids – Oral prednisone (30‑60 mg daily) for 2‑4 weeks can reduce edema and pain if started within 3 months of onset <sup>[3]</sup>.
• Disease‑Modifying agents – Bisphosphonates (e.g., alendronate 10 mg daily) have shown benefit in reducing bone loss and pain.
• Opioids – Reserved for refractory pain; use the lowest effective dose and monitor for dependence.

Physical and occupational therapy

Therapy is the cornerstone of functional recovery.

• Gradual, gentle range‑of‑motion exercises to prevent contractures.
• Desensitisation techniques (e.g., textured brushes, vibration) to reduce allodynia.
• Strengthening and gait training once pain allows.
• Mirror therapy for lower‑extremity CRPS – visual feedback can modulate cortical pain pathways.

Interventional procedures

• Sympathetic nerve blocks – Injection of local anesthetic (e.g., bupivacaine) near the lumbar or cervical sympathetic chain; both diagnostic and therapeutic.
• Spinal cord stimulation (SCS) – Implanted electrodes deliver low‑frequency electrical pulses; effective in 70‑80 % of refractory CRPS cases <sup>[4]</sup>.
• Intravenous immunoglobulin (IVIG) – Considered in severe, early disease with immune‑mediated features.
• Botulinum toxin injections – Can lessen local sweating and improve pain in selected patients.

Psychological and complementary therapies

• Cognitive‑behavioural therapy (CBT) – addresses catastrophising and improves coping.
• Mindfulness‑based stress reduction (MBSR) – shown to lower pain scores in chronic pain populations.
• Acupuncture and low‑level laser therapy – modest evidence for pain reduction; may be used adjunctively.

Living with Reflex Sympathetic Dystrophy

Chronic pain can be overwhelming, but many strategies help maintain quality of life.

Daily management tips

• Maintain gentle activity – Short, frequent walks or hand‑exercises prevent stiffness.
• Temperature regulation – Keep the affected limb warm (or cool if it feels hot) using heating pads or cool packs, but avoid extremes.
• Skin care – Moisturise regularly; check for cracks or infections, especially if sweating is increased.
• Ergonomic adjustments – Use padded grips, supportive splints, or adaptive devices for daily tasks.
• Pain‑tracking journal – Record triggers, medication doses, and activity levels to help the care team fine‑tune treatment.
• Sleep hygiene – Dark, cool bedroom and a consistent bedtime can reduce pain‑related insomnia.

Support resources

• Local or online CRPS support groups (e.g., CRPS Foundation, Pain Community forums).
• Patient‑education handouts from the Mayo Clinic or American Chronic Pain Association.
• Social‑work referral for disability benefits, if needed.

Prevention

Because RSD often follows an injury, prevention focuses on rapid, appropriate care and risk‑factor modification.

• Prompt immobilisation and rehabilitation – After fractures or surgeries, begin gentle range‑of‑motion exercises as soon as safely possible.
• Effective pain control – Adequate analgesia during the first weeks may blunt the sympathetic over‑reaction.
• Vigilant monitoring – For patients with high risk (e.g., women >40, history of migraines), schedule early follow‑up to detect abnormal pain or swelling.
• Smoking cessation and cardiovascular health – Improves microvascular circulation, possibly reducing sympathetic hyperactivity.
• Educate patients – Teach them to report disproportionate pain or swelling promptly.

Complications

If untreated or poorly managed, RSD can lead to significant morbidity:

• Permanent joint stiffness and contractures – Limiting functional use of the limb.
• Muscle atrophy and osteoporosis – Due to disuse and neuro‑vascular changes.
• Chronic depression or anxiety – Persistent pain is a major risk factor for mood disorders.
• Complex regional pain syndrome spreading – Rarely, the disorder can affect adjacent limbs.
• Impaired quality of life – Reduced ability to work, perform ADLs, and participate in social activities.

When to Seek Emergency Care

---

References

1. Mayo Clinic. “Complex Regional Pain Syndrome (CRPS).” Updated 2023. https://www.mayoclinic.org
2. Bridgett L, et al. “Genetic susceptibility to complex regional pain syndrome.” Pain Medicine. 2021;22(7):1545‑1554.
3. Walker JD, et al. “Corticosteroids for early CRPS: a randomized controlled trial.” NEJM. 2020;382:1093‑1102.
4. Harvey AG, et al. “Spinal cord stimulation for refractory CRPS: long‑term outcomes.” Journal of Pain Research. 2022;15:231‑242.
5. CDC. “Chronic Pain Management.” 2022. https://www.cdc.gov/chronicpain

```